|
(P1066) |
Noninvasive magnetic resonance imaging evaluation of increased endothelial permeability over atherosclerotic lesions using very small superparamagnetic iron oxide nanoparticles |
| |
|
W. Poller, E. Ramberger, P. Boehm-Sturm, S. Müller, K. Möller, N. Löwa, F. Wiekhorst, M. Taupitz, S. Wagner, G. Baumann, V. Stangl, A. Ludwig (Berlin) |
|
(P1067) |
Role of CD40 single nucleotide polymorphism in endothelial dysfunction in the context of coronary heart disease |
| |
|
C. S. Sultan, P. Bugert, F. Leuschner, M. Hecker, A. H. Wagner (Heidelberg, Mannheim) |
|
(P1068) |
mTOR modulation in endothelial dysfunction |
| |
|
K. Zhang, J. Burghaus, H. A. Katus, T. Althoff, M. Völkers (Heidelberg, Berlin) |
|
(P1069) |
Cigarette smoke extract abrogates atheroprotective effects of high laminar flow on endothelial function |
| |
|
S. Giebe, M. Brux, N. Cockcroft, K. Hewitt, H. Morawietz, C. Brunßen (Dresden; Southampton, UK) |
|
(P1070) |
Inhibition of eNOS phosphorylation on tyrosine656 in mice protects against endothelial dysfunction |
| |
|
J. Steck, B. Fißlthaler, K. de Silva, K. Kohlstedt, I. Fleming (Frankfurt am Main) |
|
(P1071) |
Endothelial-specific deletion of PGC-1α during chronic angiotensin II treatment leads to endothelial dysfunction, increased vascular oxidative stress and an impaired antioxidative defense |
| |
|
S. Kröller-Schön, T. Jansen, M. Oelze, A. Daiber, T. Münzel, E. Schulz (Mainz) |